A (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.

Macular degeneration, particularly age-related macular degeneration, is a leading cause of vision loss worldwide.  This ...